COLL vs META · P/E 17, rev $181.9M vs P/E 29, rev $200.97B
Collegium Pharmaceutical Inc (COLL) versus Meta Platforms Inc. (META) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Meta Platforms Inc. (META) is a internet content & information company listed on US. It is led by Mark Zuckerberg.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported META revenue for 2025-12-31 was $200.97B. Net income was $60.46B. Revenue was up 22.2% from 2024-12-31 to 2025-12-31. META currently screens at market cap $1.64T and trailing P/E 28.8.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. META currently screens at market cap $1.64T and trailing P/E 28.8.
Not investment advice. Open the COLL and META stock pages for the full models.
Not investment advice.